Alanine-261 in intracellular loop III of the human gonadotropin-releasing hormone receptor is crucial for G-protein coupling and receptor internalization.
Gonadotropin-releasing hormone (GnRH) is a decapeptide that regulates reproductive function via binding to the GnRH receptor, which is a G-protein-coupled receptor (GPCR). For several members of this family, the C-terminal domain of intracellular loop III is important in ligand-mediated coupling to G-proteins; mutations in that region can lead to constitutive activity. A specific alanine residue is involved in certain GPCRs, the equivalent of which is Ala-261 in the GnRH receptor. Mutation of this residue to Leu, Ile, Lys, Glu or Phe in the human GnRH receptor did not result in constitutive activity and instead led to complete uncoupling of the receptor (failure to support GnRH-stimulated inositol phosphate production). When this residue was mutated to Gly, Pro, Ser or Val, inositol phosphate production was still supported. All the mutants retained the ability to bind ligand, and the affinity for ligand, where measured, was unchanged. These results show that Ala-261 cannot be involved in ligand binding but is critical for coupling of the receptor to its cognate G-protein. Coupling is also dependent on the size of the residue in position 261. When the amino acid side chain has a molecular mass of less than 40 Da efficient coupling is still possible, but when its molecular mass exceeds 50 Da the receptor is uncoupled. Internalization studies on the Ala261-->Lys mutant showed a marked decrease in receptor internalization compared with the wild type, indicating that coupling is necessary for effective receptor internalization in the GnRH receptor system. Activation of protein kinase C (with PMA), but not protein kinase A (with forskolin) markedly increased the internalization of the mutant receptor while having a small effect on the wild-type receptor.
Myburgh
D B
DB
MRC Molecular Reproductive Endocrinology Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory, 7925, South Africa.
Millar
R P
RP
Hapgood
J P
JP
D000409:Alanine / Q000737:chemistry*; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D001667:Binding, Competitive; D019556:COS Cells; D005576:Colforsin / Q000494:pharmacology; D004705:Endocytosis / Q000502:physiology; D019204:GTP-Binding Proteins / Q000502:physiology*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D008024:Ligands; D016297:Mutagenesis, Site-Directed / Q000235:genetics; D011485:Protein Binding / Q000235:genetics; D011966:Receptors, LHRH / Q000737:chemistry* / Q000235:genetics; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014162:Transfection / Q000235:genetics
D007295:Inositol Phosphates; D008024:Ligands; D011966:Receptors, LHRH; D005576:Colforsin; D007987:Gonadotropin-Releasing Hormone; D019204:GTP-Binding Proteins; D013755:Tetradecanoylphorbol Acetate; D000409:Alanine